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Objectives The authors sought to characterize the left atrial (LA) and pulmonary vein (PV) electrophysiological and hemody-
namic features in obese patients with atrial fibrillation (AF).
Background Obesity is associated with increased risk for AF.
Methods A total of 63 consecutive patients with AF who had normal left ventricular (LV) ejection fraction and who under-
went catheter ablation were studied. Atrial and PV electrophysiological studies were performed at the time of
ablation with hemodynamic assessment by cardiac catheterization, and LA/LV structure and function by echo-
cardiography. Patients were compared on the basis of body mass index (BMI): 25 kg/m2 (n  19) and BMI
30 kg/m2 (n  44).
Results At a 600-ms pacing cycle length, obese patients had shorter effective refractory period (ERP) in the left atrium
(251  25 ms vs. 233  32 ms, p  0.04), and in the proximal (207  33 ms vs. 248  34 ms, p  0.001)
and distal (193  33 ms vs. 248  44 ms, p  0.001) PV than normal BMI patients. Obese patients had higher
mean LA pressure (15  5 mm Hg vs. 10  5 mm Hg, p  0.001) and LA volume index (28  12 ml/m2 vs.
21  14 ml/m2, p  0.006), and lower LA strain (5.5  3.1% vs. 8.8  2.8%; p  0.001) than normal BMI patients.
Conclusions Increased LA pressure and volume, and shortened ERP in the left atrium and PV are potential factors facilitating
and perpetuating AF in obese patients with AF. (J Am Coll Cardiol 2012;60:851–60) © 2012 by the
American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.03.042Obesity and atrial fibrillation (AF) are 2 major growing
epidemics associated with considerable morbidity and mor-
tality in the American population and globally (1). Obesity
is a risk factor for AF, as reported by the Framingham study,
and is associated with a 50% increase in the risk of AF
development (2,3). Further, obesity is associated with in-
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Atrial Fibrillation and Obesity August 28, 2012:851–60atrial (LA) dilation (3). How-
ever, the electrophysiological fea-
tures that may promote and per-
petuate AF in the obese patient
have not been studied in detail.
Pulmonary vein (PV) isolation
has been shown to be an effective
treatment for patients with AF
(6). Of the candidates for AF
ablation, 80% were overweight,
and 40% were obese (7), indicat-
ing that AF and obesity are
highly interrelated. Results from
pioneer studies and ablation out-
comes have confirmed that the
triggers located in the PVs are
responsible for the initiation of
AF in the majority of patients
with AF (6,8 –10). Whether
there are identifiable markers for
the increased propensity to AF
development in obese patients is
uncertain. Hence, in this study,
we proposed to determine the atrial and PV electrophysio-
logical and hemodynamic characteristics in obese patients
undergoing catheter-based ablation for AF.
Methods
Study patients. This single-center study enrolled 63 sub-
jects who had highly symptomatic, drug-refractory AF and
who underwent catheter-based radiofrequency PV isolation
in the electrophysiology laboratory at the Mayo Clinic,
Rochester, Minnesota, between June 2007 and September
2009. Body mass index (BMI) (weight in kilograms divided
by the square of height in meters) was determined for all
patients. Patients were categorized as normal (BMI 25
kg/m2; n  19) or obese (BMI 30 kg/m2; n  44) at the
ime of ablation. Patients with BMI 25 to 29.9 kg/m2 were
xcluded to allow comparison between the obese and those
ith truly normal body weights. Patients with a left ven-
ricular ejection fraction (LVEF) 50%, cardiomyopathy,
alvular disease, congenital heart disease, or long-lasting AF
ith a duration of more than a year were excluded. This
tudy was approved by the Mayo Clinic Institutional Review
oard, and all patients signed informed consent.
All patients underwent clinical evaluation before ablation,
hich consisted of a detailed history and physical examina-
ion, a 12-lead electrocardiography, a 24-h Holter study, a
hest multislice computed tomography, and transthoracic
nd transesophageal echocardiography. All antiarrhythmic
rugs were held for more than 5 half-lives. Amiodarone was
iscontinued 1 month before the procedure.
tudy protocol. CATHETERIZATION. All patients received
eneral anesthesia. To minimize the effect of anesthetic
Abbreviations
and Acronyms
AF  atrial fibrillation
BMI  body mass index
CS  coronary sinus
DC  direct current
dP/dt  peak rate of
LV pressure change
ERP  effective refractory
period
LA  left atrial
LAVI  left atrial volume
index
LV  left ventricular
LVEDP  left ventricular
end-diastolic pressure
LVEF  left ventricular
ejection fraction
LVESP  left ventricular
end-systolic pressure
PV  pulmonary veingents on hemodynamics, only desflurane was used for all 2tudy patients during the study. Fentanyl and midazolam
ere avoided until the study was complete.
Standard catheterization was performed by placing cath-
ters (5- to 7-F) into the right ventricle, right atrium,
oronary sinus, and His bundle region from the femoral
eins and right internal jugular vein. LA access was achieved
y a double transseptal puncture technique. A decapolar
ircular catheter (Lasso, Biosense Webster, Diamond Bar,
alifornia) was advanced through a transseptal sheath for
apping PV potentials. Intracardiac bipolar electrograms
ere displayed simultaneously on a multichannel recorder
Prucka Engineering, Houston, Texas). Patients received
eparin before transseptal puncture and throughout the
blation procedure to maintain an activated clotting time of
00 to 400 s. The study protocol was then undertaken
efore the ablation.
HEMODYNAMIC STUDY. A high-fidelity 2-F Millar catheter
was advanced to the LV via a long transseptal sheath and
multipurpose catheter. LV and LA pressure recordings were
measured simultaneously (via a saline-filled long transseptal
sheath) and stored digitally for off-line analysis. The LV and
LA pressures were measured during right atrial pacing at
cycle lengths of 800 and 600 ms, and during AF. All
pressure measurements were repeated 3 times and averaged.
Left ventricular end-systolic pressure (LVESP), the peak
rate of left ventricular pressure change (dP/dt), left ventric-
ular relaxation indicated by tau (time constant of LV
relaxation), and left ventricular end-diastolic pressure
(LVEDP) were determined. Cardioversion was performed
to resume sinus rhythm if the patient was in AF at the time
of the study.
ECHOCARDIOGRAPHIC STUDY. Standard comprehensive
echocardiography (Vivid 7, GE Medical Systems, Milwau-
kee, Wisconsin) was performed simultaneously with the
hemodynamic study. LV volume, LVEF, and left atrial
volume index (LAVI) were assessed. Mitral inflow was
obtained by pulsed-wave Doppler echocardiography with
the sample volume between mitral leaflet tips during dias-
tole, and mitral annulus velocities were obtained from the
septal annulus by tissue Doppler imaging. LA strain was
measured at LA septal and lateral segments during ventric-
ular systole and diastole. All measurements were performed
for 5 cardiac cycles and then averaged.
ELECTROPHYSIOLOGICAL STUDY. The effective refractory
eriod (ERP) of the high right atrium, LA (distal coronary
inus), and proximal and distal left superior PV was mea-
ured by a programmed single extra stimulus (Fig. 1). The
RP was defined as the longest AA interval that failed to
licit tissue response. Electrical impulses of 2.0-ms duration
t twice the pacing threshold were delivered at drive cycle
engths (S1) of 600 ms, 500 ms, and 400 ms, with premature
S2) stimulation in 10-ms decrements. The atrial extra-
timuli were introduced following an 8-beat drive train. A
-s pause was allowed between each drive train. Direct
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August 28, 2012:851–60 Atrial Fibrillation and Obesitycurrent (DC) cardioversion was performed to restore sinus
rhythm when AF was induced. The LA conduction time
was determined as the traveling time from distal coronary
sinus (CS) (pole 1, 2) to mid CS (pole 9, 10) by distal CS
pacing. A 3.5-mm open, saline-irrigated ablation catheter
(ThermoCool, Biosense Webster) was placed at the left
superior PV ostium. The longitudinal PV conduction time
was determined as the time interval from proximal to distal
recording electrodes on the ablation catheter, during distal
CS pacing. A 15-mm, 10-unipolar circular lasso catheter
was placed at the orifice of the left superior PV. Circum-
ferential PV ostial conduction was defined as the conduction
time from lasso pole 1 to pole 6 with pacing from lasso pole
1 (one-half of lasso circle) (Fig. 1). All conduction times
were measured at pacing cycle lengths of 600, 500, and 400
ms. Conduction velocity was then calculated (catheter
electrode distance divided by conduction time). At the
completion of the study, AF was induced by programmed
LA stimulation from the CS with 2 extrastimuli and burst
pacing to determine excitability of the atria.
PV AND LA 3-DIMENSIONAL MAPPING. A 3-dimensional
Figure 1 Measurement of PV Conduction and ERP
A diagrammatic demonstration of measuring pulmonary vein (PV) ostial circum-
ferential conduction and PV effective refractory period (ERP). A 10-unipolar cir-
cular recording catheter was placed at the left superior pulmonary vein ostium.
When pacing captures pole 1 electrode of the catheter, the time required for
impulse to travel from pole 1 to pole 6 was recorded. This distance is half of
the pulmonary vein ostial circumference. LA  left atrium; LIPV  left inferior
pulmonary vein; LSPV  left superior pulmonary vein.lectroanatomic mapping system (Carto XP Navigation system, Biosense Webster, or NAVX, St. Jude Medical, St.
aul, Minnesota) was used to create the anatomy of the 4
V ostia. Thereafter, an LA activation map was created in
inus rhythm. The following electroanatomic features were
ollected to examine LA myocardial substrate: 1) median
A voltage; 2) LA volume; 3) the location and total area of
lectrically silent regions (scar), defined as absence of re-
ordable activity or a bipolar voltage 0.05 mV; and 4) the
ocation and total area of low-voltage regions that were
efined as contiguous areas of bipolar voltage 0.05 and
0.5 mV.
tatistical analysis. Continuous variables are presented as
ean  SD. Patients were grouped according to BMI, and
haracteristics of the BMI groups were compared by using
-sample Student t tests, or Wilcoxon rank sum tests,
epending on the distribution of the data. Categorical
ariables were assessed with a chi-square test. Paired com-
arisons of continuous variables were accomplished with a
aired t tests. Multivariate linear regression analysis was per-
ormed to evaluate whether hypertension, diabetes, and sleep
pnea account for the difference between obese and normal
MI groups for each of the echocardiographic and electrophys-
ological outcomes. Values of p0.05 were considered significant.
esults
atient baseline characteristics. The study population
onsisted of 44 obese and 19 nonobese subjects. The mean
ge was 57  10 years. Baseline patient characteristics are
hown in Table 1. Obese patients had a higher waist/hip
atio (p  0.02) and more prevalent hypertension and sleep
pnea compared with normal BMI patients (68% vs. 32%,
 0.007; 45% vs. 5%, p  0.002, respectively). There was
o significant difference in the incidence of persistent AF
etween the 2 groups (p  0.11). In patients who presented
n sinus rhythm, the interval between the last documented
F episode and the procedure was similar in the obese
31 40 days) and normal BMI groups (32 31 days, p
.73). The majority of patients (89%) had failed treatment
ith at least 1 antiarrhythmic agent. Before the procedure,
patients were taking amiodarone, which was discontinued
n all patients (1 [5%] in the normal BMI group and 7
13%] in the obese group, p  0.42). The mean duration
rom stopping amiodarone to the procedure was 46  29
ays. More obese patients were taking statin drugs (36% vs.
%, p  0.01).
Of the 63 study patients, 52 were in sinus rhythm and 11
ere in AF at the time of the ablation procedure. These 11
atients underwent DC cardioversion (2 in the normal BMI
roup and 9 in the obese group, 10.5% vs. 14.3%, p  0.47)
efore the electrophysiology and hemodynamic studies. The
resenting AF persisted for 75  105 days in the normal
MI group and 130  112 days (p  0.59) in the obese
roup before cardioversion. The time from DC cardiover-
ion to electrophysiology study was 32  17 min and 49 
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Atrial Fibrillation and Obesity August 28, 2012:851–6016 min (p  0.37) in the normal BMI and obese groups,
respectively.
Electrophysiological features in obese patients. At a
pacing cycle length of 600 ms, the ERPs were significantly
different among the right atrium, left atrium, proximal PV,
and distal PV (p  0.001) (Fig. 2). Comparison of ERPs in
he right atrium, left atrium, and proximal and distal PV
etween normal BMI and obese patients is shown in
igure 3. At a 600-ms pacing cycle length, obese patients
ad shorter ERPs in the left atrium (233 32 ms vs. 251
5 ms, p  0.04), proximal (207  33 ms vs. 248  34 ms,
Patient Baseline CharacteristicsTable 1 Patient Baseline Characteristics
Characteristic
BMI <25 kg/m2
(n  19)
Male 11 (58)
Age, yrs 54.9 12.5
BMI, kg/m2 23.7 1.7
Waist, cm 78.9 (76.0, 103.0) 1
Hip, cm 96.3 (92.5, 102.0) 1
Waist/hip ratio 0.9 0.1
Coronary artery disease 2 (11)
Hypertension 6 (32)
Diabetes 0
Obstructive sleep apnea 1 (5)
Paroxysmal AF 13 (68)
Persistent AF 6 (32)
AF duration, yrs 7.0 (2.0, 11.0)
No. of failed AADs
0 3 (16)
1 13 (68)
2 2 (11)
3 1 (5)
Beta-blocker 13 (68)
Calcium-channel blocker 7 (37)
Statin 1 (5)
Values are n (%), mean  SD, or median (quartile). *Chi-square test.
AAD  antiarrhythmic drug; AF  atrial fibrillation; BMI  body ma
Figure 2 Comparison of ERP in Atria and PVs
A comparison of effective refractory periods (ERP) in the right atrium (RA), left
atrium (LA), proximal pulmonary vein (Prox PV), and distal pulmonary vein (Dist
PV) in all 63 patients with atrial fibrillation at a pacing cycle length of 600 ms.
Error bars represent standard deviations.p 0.001) and distal (193  33 ms vs. 248  44 ms, p 
.001) PV than normal BMI patients. This difference is
aintained at pacing cycle lengths of 500 ms and 400 ms in
he PV. Figure 4 shows LA (A1 and A2), proximal PV (B1
nd B2), and distal PV (C1 and C2) ERP for a patient with
ersistent AF and obesity.
The LA conduction velocities (1.24  0.22 m/s vs.
.18  0.30 m/s, p  0.48) and PV circumferential
onduction time (23  11 ms vs. 31  30 ms, p  0.12)
ere similar in normal BMI and obese patients. However,
he longitudinal PV conduction velocity in obese patients
as significantly slower than that in normal BMI patients at
acing cycle lengths of 600 ms (0.78  0.35 m/s vs. 1.11 
.54 m/s, p  0.05). Figure 5 shows an example of
easurement for LA conduction time (Fig. 5A), longitudi-
al PV conduction time (Fig. 5B, from proximal to distal
blation catheter), and circumferential PV conduction time
Fig. 5C, from lasso catheter pole 1, 2 to 6, 7).
There was no difference in the mode of AF induction
etween obese and normal BMI patients. AF (sustained for
ore than 5 min) was induced by programmed extrastimuli
n 26 patients (7 normal BMI, 19 obese, p 0.78) and rapid
trial burst pacing in 16 patients (4 normal BMI, 12 obese,
 0.75). After DC cardioversion, spontaneous AF re-
urred within 5 min in 6 normal BMI patients (32%) and 5
bese patients (11%) (p  0.07) before the ablation.
A comparison of atrial electrical features by 3-
imensional mapping between normal BMI and obese
30 kg/m2
 44)
Total
(N  63) p Value
3 (75) 44 (70) 0.17*
4 8.8 56.6 10.0 0.38
5 4.3 31.3 6.2 0.001
06.0, 121.9) 111.4 (101.6, 120.0) 0.001c
10.0, 120.0) 111.9 (104.0, 119.0) 0.001c
0 0.1 1.0 0.1 0.02
(16) 9 (14) 0.58*
0 (68) 36 (57) 0.007*
(18) 8 (13) 0.05
0 (46) 21 (33) 0.002*
0 (46) 33 (52) 0.11*
4 (54) 30 (48) 0.11*
(1.0, 8.0) 5.0 (1.5, 9.0) 0.14†
0.12*
4 (9) 7 (11)
7 (39) 30 (48)
6 (36) 18 (29)
(16) 8 (13)
9 (66) 42 (67) 0.85*
3 (30) 20 (32) 0.57*
6 (36) 17 (27) 0.01*
sum test.
x.BMI >
(n
3
57.
34.
14.0 (1
13.5 (1
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August 28, 2012:851–60 Atrial Fibrillation and Obesitymedian voltage, and scar areas were similar between the 2
groups (p  0.05).
emodynamic features in obese patients. The mean
sinus cycle length was 965  236 ms. When pacing at 800
ms and 600 ms as compared with sinus rhythm, the LVESP
and maximum LV dP/dt increased (p  0.01), minimum
LV dP/dt and tau decreased (p  0.01), and LVEDP was
unchanged. Compared with the normal BMI patients, the
obese patients had higher LVEDP and mean LA pressure
in sinus rhythm, whereas LVESP and maximum LV dP/dt
were not different (Fig. 6). During atrial pacing at 800 ms,
600 ms, and induced AF, the difference in LVEDP and
mean LA pressure between the 2 groups was maintained.
Figure 7 shows simultaneous LV and LA pressure record-
ings in a patient with normal BMI (Fig. 7A) and a patient
with obesity (Fig. 7B).
Echocardiographic features in obese patients. In sinus
rhythm, LV end-diastolic and systolic volume indexes and
LVEF were not different between normal BMI and obese
patients. However, the LAVI at LV end-diastole (end of
LA systole, p  0.002) and LAVI pre-A (end of diastole,
p  0.006) were significantly higher in obese patients,
esulting in a lower LA ejection fraction (p  0.001) in
obese patients compared with normal BMI patients. The E
and A flow velocity, E/A ratio, deceleration time, LA septal
E velocity, and E/E= ratio were similar between the 2
roups. Compared with the normal BMI patients, obese
atients had lower longitudinal LA strains (p  0.001)
Table 3).
ultivariate analysis for electrophysiological and hemo-
ynamic features in obese patients. Hypertension, diabe-
es, and obstructive sleep apnea were more frequently
Figure 3 Comparison of ERP in Normal BMI and Obese Patient
A comparison of the effective refractory period (ERP) in the right atrium (RA), left a
and distal LSPV between patients with normal body mass index (BMI) (n  19) anresent in obese patients compared with normal BMI oatients in this study. Multivariate linear regression model-
ng was performed to determine whether these clinical
onfounding factors affect the results. After adjustment for
ach of the individual factors, the differences between obese
nd nonobese groups continued to be significant in proximal
nd distal PV ERP, PV longitudinal conduction time,
AVI, LA strain, LVEDP, and LA mean pressure (all p 
.05).
iscussion
ain findings. Obese patients with AF showed slower
onduction from the left atrium entering the PV and a
ignificantly shorter ERP in the left atrium and PV.
owever, no significant LA substrate scarring was identi-
ed by 3-dimensional mapping in obese and normal BMI
atients. Obese patients had higher LA filling pressures and
reater extent of LA remodeling with a higher LAVI and
mpaired LA contractility. This difference remains present
fter adjustment for the clinical confounding factors, includ-
ng hypertension, sleep apnea, and diabetes, which are more
revalent in obese patients.
lectrophysiological features predisposing to AF in
bese patients. There is increasing evidence that obesity is
ssociated with greater prevalence of AF (11,12). At the
ayo Clinic, 40% of the patients who underwent PV
solation for symptomatic, drug-refractory AF were obese
ith a BMI 30 kg/m2 (7). How obesity promotes AF is
nclear. In this study, obese patients had central adipose
eposition with increased waist/hip ratio, a 2-fold higher
ncidence of hypertension, and a 9-fold higher incidence of
(LA), proximal left superior pulmonary vein (LSPV),
e patients (n  44). Error bars represent standard deviations.s
trium
d obesbstructive sleep apnea compared with normal BMI pa-
856 Munger et al. JACC Vol. 60, No. 9, 2012
Atrial Fibrillation and Obesity August 28, 2012:851–60tients, similar to our previous reports and those from others
(13,14).
We have noted that the ERPs were shortened in the
order of right atrium, left atrium, proximal PV, and distal
PV, consistent with the findings from other reports (15,16).
Here, we report the novel finding that the ERPs in the
proximal and distal PV in obese patients were substantially
shorter than those in normal BMI patients. The shortened
ERP in the PVs could be a potential mechanism of
sustaining or perpetuating AF in obese patients. Conversely,
AF may shorten the PV ERP, and hence, promote “AF
begets AF.” Although the elapsed time of the last episode of
AF prior to the study was 31 days on average in this study,
and similar between obese and normal BMI groups, Ros-
tock et al. (17) have shown evidence that a brief episode of
AF shortens ERP and slows conduction of PV to a greater
extent than the atria. Further, to investigate the mechanism
of AF initiation by premature atrial contraction in the PV,
Narayan et al. (18) made a novel finding that an action
potential duration restitution slope1 near the PVs enables
Figure 4 ERP Measurement
An example of effective refractory period (ERP) measured in the left atrium (A1 an
proximal pulmonary vein (B1 and B2, ERP 190 ms at a pacing cycle length of 600
at a pacing cycle length of 600 ms from distal ablation catheter). ABL D  distalsingle premature atrial beats to initiate AF in patients withparoxysmal AF. By contrast, marked activation delay near
PVs and flattened action potential duration restitution are
the features of persistent AF (18). We could speculate that
obese subjects may have the electrical substrate predisposing
atria to fibrillation initiation in the PVs (triggers) and prone
to sustaining AF. The atrial ERPs were also shortened,
though more modestly, in obese patients in our study. The
longitudinal conduction velocity from left atrium to PV was
slower in obese patients than that in normal BMI patients.
The LA conduction velocity did not differ between the 2
groups. This observation was in agreement with the finding
from electroanatomic mapping that only limited atrial
pathological substrate (LA endocardial fibrosis or scarring)
was present in both obese and normal BMI patients, despite
the presence of hemodynamic stress with larger LA volume,
depressed LA function, and impaired diastolic function in
the obese group. The absence of extensive LA structural
remodeling may be due to exclusion of patients with
long-standing AF or structural heart diseases. However, a
direction-dependent conduction abnormality was notable in
ERP 210 ms at a pacing cycle length of 600 ms from coronary sinus catheter),
om distal ablation catheter), and distal pulmonary vein (C1 and C2, ERP 170 ms
n catheter; ABL P  proximal ablation catheter; CS  coronary sinus.d A2,
ms fr
ablatiopatients with lone AF, but not in control subjects (19). AF
857JACC Vol. 60, No. 9, 2012 Munger et al.
August 28, 2012:851–60 Atrial Fibrillation and Obesitymechanisms other than myocardial fibrosis, such as auto-
nomic imbalance and LA stretching, may contribute to the
initiation of and perpetuation of AF. Indeed, using a
stretch-related AF model in the sheep heart, Kalifa et al.
(20) reported a positive correlation between intra-atrial
Figure 5 Measurement of Atrial and PV Conduction
An example of conduction time measurement. (A) Left atrial conduction time
from coronary sinus catheter bipolar electrodes 1, 2 to electrodes 9, 10 was
40 ms. (B) Longitudinal PV conduction time from proximal to distal ablation
catheter was 12 ms. (C) Circumferential PV conduction time from lasso circu-
lar catheter electrodes 1, 2 to electrodes 6, 7 was 23 ms. Abbreviations as in
Figures 1 and 4.
Comparison of LA Substrate Between Normal BTable 2 Comparison of LA Substrate Betwe
Characteristic
BMI <25 kg/m2
(n  19)
No. of LA mapping points 69.1 17.5
LA activation time, ms 110.0 (106.0, 118.0
LA voltage, mV 1.3 (1.2, 1.9)
Highest 6.1 1.9
Lowest 0.1 (0.1, 0.3)
Scar area (0.05 mV), cm2 0.0 (0.0, 0.0)
Low-voltage area (0.5 mV), cm2 2.8 (0.0, 3.9)Values are mean  SD or median (quartile). *Rank sum test.
BMI  body mass index; LA  left atrial.pressure and the number of waves emanating from the left
superior PV, but not from the LA free wall. A higher
maximum dominant frequency in the LA superior PV junc-
tion, as compared with the LA free wall, was observed when
measured LA pressure is increased above 10 cm H2O (20).
LV diastolic dysfunction and atrial structural remodeling
in obese patients. A unique feature of our study is the
simultaneous hemodynamic measurements by cardiac cath-
eterization and noninvasive echocardiography to assess in-
tracardiac pressures and LV systolic and diastolic function in
the electrophysiology laboratory. LV contractility and sys-
tolic function in obese patients were comparable to those in
normal BMI patients. However, the indexes of LV diastolic
function, including the LV filling pressures (LVEDP and
mean LA pressure) were significantly elevated in obese
patients compared with normal BMI patients. Such differ-
ences were present during sinus rhythm and in AF. In
addition, the LAVI at the end of LA diastole and systole,
measured by 2-dimensional echocardiography, was higher
and LA ejection fraction was lower in obese patients.
Although the Doppler study did not show evidence of LV
diastolic dysfunction, given the findings of normal E/A
ratio, E/E=, and deceleration time in obese patients, the LA
strain was reduced, consistent with impaired LA stretching
and contraction in obese patients. A previous study has
shown that a higher BMI was associated with elevated LV
diastolic pressure after controlling for the end-diastolic
volume (21). Elevated LV filling pressures stretch the left
atrium and increase LA wall strain, leading to LA dilation.
LA dilation is associated with an increased risk of AF (3).
In addition, the increased circulating volume (obliged by a
larger body mass) may be a pathophysiological cause of atrial
enlargement (5,22,23). The present study clearly showed
significant elevation in LV diastolic pressure, mean LA
pressure, and impaired LV relaxation in obese patients.
These findings indicate that cardiac catheterization is more
sensitive than Doppler techniques in detecting LV diastolic
dysfunction. However, the major cardiac chamber of inter-
est in obese patients appears to be the left atrium, where
hemodynamics parameters, LA strain, and echographic
measurements all indicate the presence of structural and
functional impairments.
d Obese Patientsrmal BMI and Obese Patients
BMI >30 kg/m2
(n  44)
Total
(N  63) p Value
67.1 19.6 67.6 18.9 0.76
120.0 (95.0, 135.0) 116.0 (98.0, 130.) 0.51*
1.1 (0.6, 1.5) 1.2 (0.9, 1.5) 0.11*
5.9 2.8 6.0 2.5 0.87
0.1 (0.1, 0.2) 0.1 (0.1, 0.2) 0.68*
0.0 (0.0, 0.0) 0.0 (0.0, 0.0) 0.42*
2.5(0.0, 8.4) 2.5 (0.0, 5.6) 0.59*MI anen No
)
p
T
e
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atients undergoing catheter ablation for symptomatic AF.
he patient population may not be representative of the
pidemiological obese population with AF (e.g., those with
F without symptoms). This study did not include a control
roup of obese subjects without AF, which could provide
dditional information for the pathophysiology of AF in
besity. Only consented patients were enrolled; hence,
Figure 6 Comparison of Hemodynamics Between Normal BMI a
Comparison of left ventricular end-systolic pressure (LVESP), left ventricular end-di
and mean left atrial (LA) pressure between patients with normal body mass index
Figure 7 Intracardiac Pressure Measurement
Simultaneous left atrial pressure (LAP) and left ventricular pressure (LVP) recordin
LV pressure 95/3 mm Hg) and in an obese patient (B) (LA mean pressure 21 mmpatient selection bias could weaken the results. Some
patients with persistent AF required DC cardioversion to
provide measurements in sinus rhythm. Electrical remodel-
ing or atrial mechanical stunning after cardioversion may
affect the electrophysiological and hemodynamic results.
However, the hemodynamic and echocardiographic mea-
surements within each case were comparable. The collection
of LA mapping points using electroanatomical mapping may
bese Patients
pressure (LVEDP), time constant of left ventricular relaxation (tau),
and obese patients. Error bars represent standard deviations.
patient with normal BMI (A) (LA mean pressure 5 mm Hg,
V pressure 90/16 mm Hg). Abbreviations as in Figure 6.nd O
astolic
(BMI)gs in a
Hg, L
ial volum
me.
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August 28, 2012:851–60 Atrial Fibrillation and Obesitynot be sufficient to assess small area of atrial fibrosis.
Because the PV ostial diameter may be variable in each
patient, the measured circumferential PV conduction time
could be falsely shortened by using a standard 15-mm lasso
in those patients with small veins. Also, the difference in
conduction velocity at a faster rate or shorter cycle length of
150 to 250 ms, typically seen in AF, was not determined in
this study. Although LA pressure and volume overload were
more apparent in the obese group, the changes in LA
electrical remodeling is modest. No significant atrial scar-
ring or impaired conduction velocity was noted in this study.
Inclusion of patients with long-standing AF may provide
further information.
Conclusions
To our knowledge, this is the first mechanistic study to
characterize the electrophysiological, hemodynamic, and
echocardiographic properties in obese patients with AF.
Factors that contribute to the predisposition and perpetua-
tion of AF in obese patients include shortened ERP, slowed
conduction in the PV ostia, elevated LA filling pressure, LV
diastolic dysfunction, impaired LA stretching and contrac-
tion, and enlarged LA volume. The mechanism that under-
lies atrial and PV electrophysiological remodeling from
hemodynamic stress and predisposes obese patients to AF
remains to be determined.
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